NCT00736658View on ClinicalTrials.gov

AZD1386 Japanese Multiple Ascending Dosing Study

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 30, 2008

Study Completion Date

September 30, 2008

Conditions
Chronic Pain
Interventions
DRUG

AZD1386

Oral admin. of doses at 11 days through a 12 days period.

DRUG

Placebo

Oral admin. of doses at 11 days through a 12 days period.

Trial Locations (1)

Unknown

Research Site, Fukuoka

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY